Open Access

Conservation and sustainable use of medicinal plants: problems, progress, and prospects

Chinese Medicine201611:37

https://doi.org/10.1186/s13020-016-0108-7

Received: 20 April 2015

Accepted: 15 July 2016

Published: 30 July 2016

Abstract

Medicinal plants are globally valuable sources of herbal products, and they are disappearing at a high speed. This article reviews global trends, developments and prospects for the strategies and methodologies concerning the conservation and sustainable use of medicinal plant resources to provide a reliable reference for the conservation and sustainable use of medicinal plants. We emphasized that both conservation strategies (e.g. in situ and ex situ conservation and cultivation practices) and resource management (e.g. good agricultural practices and sustainable use solutions) should be adequately taken into account for the sustainable use of medicinal plant resources. We recommend that biotechnical approaches (e.g. tissue culture, micropropagation, synthetic seed technology, and molecular marker-based approaches) should be applied to improve yield and modify the potency of medicinal plants.

Background

Medicinal plants are globally valuable sources of new drugs [14]. There are over 1300 medicinal plants used in Europe, of which 90 % are harvested from wild resources; in the United States, about 118 of the top 150 prescription drugs are based on natural sources [5]. Furthermore, up to 80 % of people in developing countries are totally dependent on herbal drugs for their primary healthcare, and over 25 % of prescribed medicines in developed countries are derived from wild plant species [4]. With the increasing demand for herbal drugs, natural health products, and secondary metabolites of medicinal plants, the use of medicinal plants is growing rapidly throughout the world [1, 6].

A highly conservative estimate states that the current loss of plant species is between 100 and 1000 times higher than the expected natural extinction rate and that the Earth is losing at least one potential major drug every 2 years [7]. According to the International Union for Conservation of Nature and the World Wildlife Fund, there are between 50,000 and 80,000 flowering plant species used for medicinal purposes worldwide. Among these, about 15,000 species are threatened with extinction from overharvesting and habitat destruction [8] and 20 % of their wild resources have already been nearly exhausted with the increasing human population and plant consumption [9]. Although this threat has been known for decades, the accelerated loss of species and habitat destruction worldwide has increased the risk of extinction of medicinal plants, especially in China [1, 10], India [10, 11], Kenya [11], Nepal [11], Tanzania [12] and Uganda [12].

The conservation and sustainable use of medicinal plants have been studied extensively [13, 14]. Various sets of recommendations have been compiled regarding their conservation, including the establishment of systems for species inventorying and status monitoring, and the need for coordinated conservation practices based on both in situ and ex situ strategies [4]. For medicinal plants with increasingly limited supplies, sustainable use of wild resources can be an effective conservation alternative. In China and South Africa, the situation is particularly critical because of the high demands of large populations.

This article reviews global trends, developments and prospects of the strategies and methodologies concerning the conservation and sustainable use of medicinal plant resources.

Review

Literature search

We conducted systematic literature searches in the ISI Web of Science, PubMed and CNKI databases using search terms (e.g. “medicinal plant”, “herbal drug”, “herbal medicine”, “aromatic plant”, and “Chinese medicine”) and keyword combinations (e.g. “in situ conservation”, “ex situ conservation”, “sustainable use”, and “cultivation practice”) to retrieve the abstracts of relevant articles (Fig. 1). The literature search spanned the period from January 2000 to December 2014, and the languages were limited to English and Chinese. We carefully reviewed all retrieved abstracts to find articles that were suitable according to the inclusion criteria (Table 1). For literature focusing on the conservation and/or sustainable use of medicinal plants, we retrieved full articles from full-text databases (ScienceDirect, Wiley, Biomed, Springer, Medline, Scopus, Elsevier, Highwire, Mcgill, Cogprints, Emedicine, Nature and Science online). From the initial search, a total of 673 abstracts were collected, including research articles, reviews, commentaries and letters. After systematic screening, 231 met the inclusion criteria. From these, full copies of 106 articles were retrieved for further evaluation. In addition, we retrieved 25 non-indexed but relevant citations from the reference lists of retrieved articles to supplement the above searches and provide a complete literature retrieval.
Fig. 1

Diagram for literature selection

Table 1

The inclusion and exclusion criteria for study selection

Subjects

Criteria description

Inclusion criteria

The subject is about medicinal plants

The purpose is to conserve or sustainably use

It has a detailed description of the strategy of conservation, sustainable use or resource management

Consistent to the three items simultaneously

Exclusion criteria

The subject is not related to medicinal plants (e.g. animals or mineral substances)

The purpose is not for conservation or sustainable use of medicinal plants (e.g. herb extraction, drug discovery, chemical constituent or pharmacological property)

It has no description of the strategy of conservation, sustainable use or resource management of medicinal plants

Diversity of medicinal plants used worldwide

More than one-tenth of plant species are used in drugs and health products, with more than 50,000 species being used. However, the distribution of medicinal plants is not uniform across the world [15, 16]. For example, China and India have the highest numbers of medicinal plants used, with 11,146 and 7500 species, respectively, followed by Colombia, South Africa, the United States, and another 16 countries with percentages of medicinal plants ranging from 7 % in Malaysia to 44 % in India versus their total numbers of plant species [1619] (Fig. 2). Certain plant families not only have higher numbers of medicinal plants, but also have higher proportions of threatened species than others [15]. Only a portion of medicinal plants that suffer from genetic erosion and resource destruction have been listed as threatened [20, 21].
Fig. 2

Number and percentage of medicinal plant species in different countries. The light bars indicate the number of medicinal plant species, and the dark dots indicate the percentage of medicinal plants compared with the total number of plant species. Data sources from Rafieian-Kopaei [16], Hamilton [17], Marcy et al. [18], and Srujana et al. [19]

Factors related to species rarity of medicinal plants

Species rarity is used to assess the extinction risk of medicinal plants, and to identify those species most at risk of extinction, prior to commencement of conservation efforts [22]. It is necessary to determine how rare each species is and in which ways rare species differ from one another. Not all medicinal plants are affected in the same way by harvesting pressures [23, 24]. Overexploitation, indiscriminate collection, uncontrolled deforestation, and habitat destruction all affect species rarity, but are insufficient to explain individual species susceptibility or resilience to harvest pressure. Multiple biological characters correlate with extinction risk, such as habitat specificity, distribution range, population size, species diversity, growth rate, and reproductive system (Table 2; Fig. 3).
Table 2

Summary of original investigations into the conservation and sustainable use of medicinal plants

Sources

Objectives

Features and study design

Findings and conclusions

Andel and Havinga [24]

249 medicinal plants in Suriname

Carried out a market survey to look for signs of overharvesting by analyzing the market, harvesters and post-harvest survival of the medicinal plants

Less than half of the medicinal plants were harvested exclusively from the wild, and leaves were the main products. Most medicinal plants were harvested from secondary forest or man-made vegetation. It didn’t invariably lead to the resource decline or species loss

Semwal et al. [26]

Ten rare and endangered medicinal plants

Based on the density, occurrence habitats and pressure level to evaluate the distribution pattern, population structure and conservation status of medicinal plants

It grouped the medicinal plants into restricted distribution with high pressure and well distributed with low pressure, providing insights for the conservation and management strategies of medicinal plants

Long et al. [32]

Amorphophallus, Paris, Musella lasiocarpa, and Camellia sinensis

Dealt with strategies for agrobiodiversity conservation and promotion based on studies of the medicinal plants in the Yunnan Province of China

Strategies (e.g. in situ and ex situ conservation, as well as the promotion and conservation of agrobiodiversity through sustainable uses) should be adopted to conserve and promote agrobiodiversity

Strandby and Olsen [41]

Abies guatemalensis

From December 2004 to August 2007 conducted a nation-wide survey with plantation owners (n = 26), retailers (n = 67) and urban consumers (n = 993)

It emphasized the importance of increasing legal supplies through decreasing plantation production costs and involving local communities in managing in situ resources

Yu et al. [44]

Rheum tanguticum

Employed a GIS-based program TCMGIS-II to integrate geographic, climate and soil type databases of China to predict the potential distribution of R. tanguticum

It found the potential habitats sharing similar ecological factors with native habitats appropriate for R. tanguticum growth. It is useful in the conservation planning and regional management of medicinal plants

Yuan et al. [47]

Scutellaria baicalensis

Estimated the genetic diversity and structure of 28 wild and 22 cultivated populations of S. baicalensis using three polymorphic chloroplast fragments

The conservation-by-cultivation is effective in protecting genetic resources, while the wild resources still need to be protected in situ. The evolutionary consequences of extensive seed exchange should be monitored carefully

Maunder et al. [49]

27 threatened medicinal plants

Surveyed 119 botanic gardens in 29 European countries, and 25 botanic gardens in 14 countries undertaking 51 conservation projects

Most medicinal plants were in a small number of collections and out of the range countries, without being included in any specific conservation project. Botanic garden collections were skewed towards ornamental species, and did not fully reflect conservation priorities

GIS geography information systems, TCMGIS-II the second version of GIS based program for the distribution prediction of traditional Chinese medicine

Fig. 3

Factors contributing to the susceptibility or resilience of medicinal plants in response to collection pressure. Factors include distribution range, habitat specificity, population size, species diversity, growth rate, and reproductive system. The dark line indicates less susceptible characteristics of medicinal plants, while the dashed line indicates more susceptible characteristics contributing to the rarity of medicinal plants

Conservation strategies

Medicinal plant resources are being harvested in increasing volumes, largely from wild populations. Indeed, demand for wild resources has increased by 8–15 % per year in Europe, North America, and Asia in recent decades [8, 9]. There is a threshold below which species reproductive capacity becomes irreversibly reduced [25, 26]. Various sets of recommendations relating to the conservation of medicinal plants have been developed, such as providing both in situ and ex situ conservation (Table 2) [15, 27]. Natural reserves and wild nurseries are typical examples to retain the medical efficacy of plants in their natural habitats, while botanic gardens and seed banks are important paradigms for ex situ conservation and future replanting [28, 29] (Fig. 4). The geographic distribution and biological characteristics of medicinal plants must be known to guide conservation activities, e.g. to assess whether species conservation should take place in nature or in a nursery.
Fig. 4

Diagram of methodological systems involved in the conservation of medicinal plants

In situ conservation

Most medicinal plants are endemic species, and their medicinal properties are mainly because of the presence of secondary metabolites that respond to stimuli in natural environments, and that may not be expressed under culture conditions [22, 29]. In situ conservation of whole communities allows us to protect indigenous plants and maintain natural communities, along with their intricate network of relationships [30]. Additionally, in situ conservation increases the amount of diversity that can be conserved [31], and strengthens the link between resource conservation and sustainable use [32]. In situ conservation efforts worldwide have focused on establishing protected areas and taking an approach that is ecosystem-oriented, rather than species-oriented [33]. Successful in situ conservation depends on rules, regulations, and potential compliance of medicinal plants within growth habitats [25, 34].

Natural reserves

The degradation and destruction of habitats is a major cause of the loss of medicinal plant resources [35]. Natural reserves are protected areas of important wild resources created to preserve and restore biodiversity [36, 37]. Around the world, more than 12,700 protected areas have been established, accounting for 13.2 million km2, or 8.81 % of the Earth’s land surface [38]. Conserving medicinal plants by protecting key natural habitats requires assessing the contributions and ecosystem functions of individual habitats [39].

Wild nurseries

It is impossible to designate every natural wild plant habitat as a protected area, owing to cost considerations and competing land uses [25, 40]. A wild nursery is established for species-oriented cultivating and domesticating of endangered medicinal plants in a protected area, natural habitat, or a place that is only a short distance from where the plants naturally grow [4, 20, 41]. Although the populations of many wild species are under heavy pressure because of overexploitation, habitat degradation and invasive species, wild nurseries can provide an effective approach for in situ conservation of medicinal plants that are endemic, endangered, and in-demand [27, 42].

Ex situ conservation

Ex situ conservation is not always sharply separated from in situ conservation, but it is an effective complement to it, especially for those overexploited and endangered medicinal plants with slow growth, low abundance, and high susceptibility to replanting diseases [4, 43, 44]. Ex situ conservation aims to cultivate and naturalize threatened species to ensure their continued survival and sometimes to produce large quantities of planting material used in the creation of drugs, and it is often an immediate action taken to sustain medicinal plant resources [45, 46]. Many species of previously wild medicinal plants can not only retain high potency when grown in gardens far away from the habitats where they naturally occur, but can have their reproductive materials selected and stored in seed banks for future replanting [4].

Botanic gardens

Botanic gardens play an important role in ex situ conservation [43], and they can maintain the ecosystems to enhance the survival of rare and endangered plant species [38]. Although living collections generally consist of only a few individuals of each species and so are of limited use in terms of genetic conservation [47], botanic gardens have multiple unique features. They involve a wide variety of plant species grown together under common conditions, and often contain taxonomically and ecologically diverse flora [48]. Botanic gardens can play a further role in medicinal plant conservation through the development of propagation and cultivation protocols, as well as undertaking programs of domestication and variety breeding [49].

Seed banks

Seed banks offer a better way of storing the genetic diversity of many medicinal plants ex situ than through botanic gardens, and are recommended to help preserve the biological and genetic diversity of wild plant species [50, 51]. The most noteworthy seed bank is the Millennium Seed Bank Project at the Royal Botanic Gardens in Britain [51]. Seed banks allow relatively rapid access to plant samples for the evaluation of their properties, providing helpful information for conserving the remaining natural populations [50, 51]. The challenging tasks of seed banking are how to reintroduce the plant species back into the wild and how to actively assist in the restoration of wild populations [50].

Cultivation practice

Although wild-harvested resources of medicinal plants are widely considered more efficacious than those that are cultivated, domestic cultivation is a widely used and generally accepted practice [30, 52, 53]. Cultivation provides the opportunity to use new techniques to solve problems encountered in the production of medicinal plants, such as toxic components, pesticide contamination, low contents of active ingredients, and the misidentification of botanical origin [54]. Cultivation under controlled growth conditions can improve the yields of active compounds, which are almost invariably secondary metabolites, and ensures production stability (Table 3). Cultivation practices are designed to provide optimal levels of water, nutrients, optional additives, and environmental factors including temperature, light and humidity to obtain improved yields of target products [27, 55]. Moreover, increased cultivation contributes to decreases in the harvest volume of medicinal plants, benefits the recovery of their wild resources, and decreases their prices to a more reasonable range [4, 13, 20] (Fig. 5).
Table 3

The advantages and disadvantages of wild resource versus cultivated medicinal plant species

Characteristics

Wild resource

Cultivated species

Advantages

It is open access resource without investment

It relieves harvesting pressure on rare and threatened species

It is natural resource and free from pesticides

It can keep genotypes being standardized or improved

Wild resource is supposed to be more efficacious

It guarantees continuing supply of raw medicinal materials

Production volume and price can be stable for longer periods

Disadvantages

Wild resource is becoming scarce and threatened by over-harvesting

It needs substantial investment before and during production

There exists a risk of adulterations and resource exhaustion

It narrows genetic diversity in gene pool of wild populations

Uncontrolled harvesting leads to the extinction of ecotype and species

Reintroduced plants can cause genetic pollution of wild resource

There is a lack of resource inventories and related management practices

Cultivated species may have negative impacts on ecosystems

There is a lack of successful cultivation techniques for some species

Information from Hamilton [4], Schippmann et al. [20], Liu et al. [27], and Raina et al. [54]

Fig. 5

Price and harvest volume variation in the transition from wild-harvesting to cultivation of medicinal plants. As wild resources decline with overharvesting, the price of raw material increases accordingly. Therefore, cultivation becomes economically feasible for price stabilization and resource recovery of medicinal plants. Data sources from Hamilton [4], Larsen and Olsen [13], Schippmann et al. [20], Chan et al. [56], and Schippmann et al. [67]

Good agricultural practices (GAP)

Good agricultural practices (GAP) for medicinal plants have been formulated to regulate production, ensure quality, and facilitate the standardization of herbal drugs [56]. A GAP approach ensures high quality, safe and pollution-free herbal drugs (or crude drugs) by applying available knowledge to address various problems [57]. GAP include comprehensive items, such as the ecological environment of production sites, germplasm, cultivation, collection, and quality aspects of pesticide detection, macroscopic or microscopic authentication, chemical identification of bioactive compounds, and inspection of metal elements [58]. Many countries actively promote the implementation of GAP. For example, Chinese authorities have promoted GAP for the growth of commonly used herbal drugs in regions where those medicinal plants are traditionally cultivated [27, 33].

Organic farming has received increasing attention for its ability to create integrated, humane, and environmentally and economically sustainable production systems for medicinal plants, [59, 60]. The aims of organic farming of medicinal plants include producing material with better quality and high productivity, and ensuring the conservation and sustainable utilization of those plants (Table 4). The defining characteristic of organic farming is the non-use of synthetic fertilizers, pesticides and herbicides, which are not allowed according to many current organic certification standards in Europe and North America [59]. Organic farming is benign to the environment, and relies upon farm-derived renewable resources to maintain biological processes of medicinal plants and ecological balance of habitates [56, 59]. The use of organic fertilizers continuously supplies soil nutrients and improves soil stability, significantly affecting the growth of medicinal plants and the biosynthesis of essential substances. For example, when organic fertilizers were applied, the biomass yield of Chrysanthemum balsamita was increased and its essential oil content was high relative to those free from organic fertilizers [61]. Organic farming of medicinal plants is becoming increasingly important in the long-term development and sustainability of medicinal plants [60].
Table 4

The characteristics and advantages of organic farming of medicinal plants

Subjects

Characteristics and advantages of organic farming

Medicinal plants

To produce material in optimal quality and sufficient quantity

To increase growth rate and biomass yield of medicinal plants

To enhance the biosynthesis of efficacious substances

To maintain the genetic diversity of medicinal plants

To protect medicinal plants against pests and disease

Environmental effects

To prohibit the use of synthetic pesticides and fertilizers

To promote sustainable use and proper care of production systems

To enhance plant diversity and biotype conservation

To protect wildlife habitats (e.g. micro-organisms, soil fora and fauna)

To enhance soil rich in macro and microelements

To conserve soil properties, fertility, productivity and system stability

To use organic fertilizers and renewable resources to minimize all forms of pollution

Economic prospects

To increase market opportunity

To maintain high market price

To achieve optimal quality and economic returns

To secure economic growth and social stability

Information from Rigby and Cáceres [59], Macilwain [60] and Suresh [61]

Sustainable use

For medicinal plants with limited abundance and slow growth, destructive harvesting generally results in resource exhaustion and even species extinction [13, 62]. Therefore, the sustainable use of medicinal plants should be considered, and good harvesting practices must be formulated. Root and whole-plant harvesting is more destructive to medicinal plants (e.g. herbs, shrubs and trees) than collecting their leaves and flowers or buds (Table 5). For herbal drugs made of whole plants or roots, using their leaves as a remedy can be a benign alternative. For example, Wang et al. [63] discovered that extracts from ginseng leaf-stems and roots have similar pharmacological activities, but ginseng leaf-stem has the advantage of being a more sustainable resource.
Table 5

Susceptibility of species to overharvesting regarding life forms and plant parts used

Life form

Percent

(%)

Leave

Flower/bud

Fruit/seed

Bark

Root

Whole plant

Herb

52

Medium

Medium

High

None

High

High

Shrub

16

Low

Low

Low

High

High

High

Tree

22

Low

Low

Low

High

High

High

Information from Schippmann et al. [67] and Teklehaymanot and Giday [68]

Prospects

The development of genetic engineering has led to the feasibility of large-scale biosynthesis of natural products, and advancements in tissue culture and fermentation of medicinal plants have opened new avenues for the large-scale and highly efficient production of desirable bioactive compounds. Tissue culture (including plant cell and transgenic hairy root culture) is a promising alternative for the production of rare and high-value secondary metabolites of medical importance [64]. Micropropagation via tissue encapsulation of propagules can not only facilitate storage and transportation, but also promotes higher regeneration rates [62]. When the amounts of normal seeds are insufficient for propagation, synthetic seed technology, defined as artificially encapsulated somatic embryos (or other tissues) could be used for cultivate in vitro or ex vitro, is a feasible alternative [65, 66]. Furthermore, breeding improvements can be carried out using molecular marker-based approaches applied at the genetic level, and the time required for breeding may be significantly shortened [62, 64, 65].

Conclusion

Despite the existence of various sets of recommendations for the conservation and sustainable use of medicinal plants, only a small portion of these have achieved adequate protection of medicinal plant resources through conventional conservation in natural reserves or botanic gardens.

Abbreviations

GAP: 

good agricultural practices

Declarations

Authors’ contributions

SC and HY conceived and designed the study. SC, HY, HL and QW carried out the article searches. HY, QW and CL performed data analysis. SC, HY, HL and QW wrote the manuscript. CL and AS revised the manuscript. All authors read and approved the final manuscript.

Acknowledgements

This study was supported by the National Natural Science Foundation of China (30900113) and the Natural Science Foundation of Shandong Province (ZR2013CQ038). All authors thank Dr. Xi-Wen Li, Liang Dong and Christine Leon for their helps on group discussion and manuscript polishing.

Competing interests

The authors declare that they have no competing interests.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
(2)
Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences
(3)
Shandong Center of Crop Germplasm Resources
(4)
School of Pharmacy, Guilin Medical University
(5)
Plant Molecular Biology Laboratory, Centre de Recherche Public-Sante´

References

  1. Nalawade SM, Sagare AP, Lee CY, Kao CL, Tsay HS. Studies on tissue culture of Chinese medicinal plant resources in Taiwan and their sustainable utilization. Bot Bull Acad Sin. 2003;44:79–98.Google Scholar
  2. Chen SL, Yao H, Han JP, Liu C, Song JY, Shi LC, Zhu YJ, Ma XY, Gao T, Pang XH, Luo K, Li Y, Li XW, Jia XC, Lin YL, Leon C. Validation of the ITS2 region as a novel DNA barcode for identifying medicinal plant species. PLoS ONE. 2010;5:e8613.View ArticlePubMedPubMed CentralGoogle Scholar
  3. Chacko SM, Thambi PT, Kuttan R, Nishigaki I. Beneficial effects of green tea: a literature review. Chin Med. 2010;5:13.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Hamilton AC. Medicinal plants, conservation and livelihoods. Biodivers Conserv. 2004;13:1477–517.View ArticleGoogle Scholar
  5. Balunas MJ, Kinghorn AD. Drug discovery from medicinal plants. Life Sci. 2005;78:431–41.View ArticlePubMedGoogle Scholar
  6. Cole IB, Saxena PK, Murch SJ. Medicinal biotechnology in the genus scutellaria. In Vitro Cell Dev Plant. 2007;43:318–27.View ArticleGoogle Scholar
  7. Pimm S, Russell G, Gittleman J, Brooks T. The future of biodiversity. Science. 1995;269:347.View ArticlePubMedGoogle Scholar
  8. Bentley R, editor. Medicinal plants. London: Domville-Fife Press; 2010. p. 23–46.Google Scholar
  9. Ross IA, editor. Medicinal plants of the world (volume 3): chemical constituents, traditional and modern medicinal uses. New Jersey: Humana Press Inc; 2005. p. 110–32.Google Scholar
  10. Heywood VH, Iriondo JM. Plant conservation: old problems, new perspectives. Biol Conserv. 2003;113:321–35.View ArticleGoogle Scholar
  11. Hamilton AC. Medicinal plants in conservation and development: case studies and lessons learned. In: Kala CP, editor. Medicinal plants in conservation and development. Salisbury: Plantlife International Publisher; 2008. p. 1–43.Google Scholar
  12. Zerabruk S, Yirga G. Traditional knowledge of medicinal plants in Gindeberet district, Western Ethiopia. S Afr J Bot. 2012;78:165–9.View ArticleGoogle Scholar
  13. Larsen HO, Olsen CS. Unsustainable collection and unfair trade? uncovering and assessing assumptions regarding Central Himalayan medicinal plant conservation. Biodivers Conserv. 2007;16:1679–97.View ArticleGoogle Scholar
  14. Uprety Y, Asselin H, Dhakal A, Julien N. Traditional use of medicinal plants in the boreal forest of Canada: review and perspectives. J Ethnobiol Ethnomed. 2012;8:1–14.View ArticleGoogle Scholar
  15. Huang H. Plant diversity and conservation in China: planning a strategic bioresource for a sustainable future. Bot J Linn Soc. 2011;166:282–300.View ArticlePubMedGoogle Scholar
  16. Rafieian-Kopaei M. Medicinal plants and the human needs. J Herb Med Pharm. 2013;1:1–2.Google Scholar
  17. Hamilton A. Medicinal plant and conservation: issues and approaches. UK: WWF; 2003.Google Scholar
  18. Marcy J, Balunasa A, Kinghornb D. Drug discovery from medicinal plants. Life Sci. 2005;78:431–41.View ArticleGoogle Scholar
  19. Srujana ST, Babu KR, Rao BSS. Phytochemical investigation and biological activity of leaves extract of plant Boswellia serrata. Pharm Innov. 2012;1:22–46.Google Scholar
  20. Schippmann U, Leaman DJ, Cunningham AB, Walter S. Impact of cultivation and collection on the conservation of medicinal plants: global trends and issues. III WOCMAP congress on medicinal and aromatic plants: conservation, cultivation and sustainable use of medicinal and aromatic plants; 2005. Chiang Mai.Google Scholar
  21. Deeb T, Knio K, Shinwari ZK, Kreydiyyeh S, Baydoun E. Survey of medicinal plants currently used by herbalists in Lebanon. Pak J Bot. 2013;45:543–55.Google Scholar
  22. Figueiredo MSL, Grelle CEV. Predicting global abundance of a threatened species from its occurrence: implications for conservation planning. Divers Distrib. 2009;15:117–21.View ArticleGoogle Scholar
  23. Wagh VV, Jain AK. Status of threatened medicinal plants of Jhabua district, Madhya Pradesh, India. Ann Plant Sci. 2013;2:395–400.Google Scholar
  24. Andel TV, Havinga R. Sustainability aspects of commercial medicinal plant harvesting in Suriname. Forest Ecol Manag. 2008;256:1540–5.View ArticleGoogle Scholar
  25. Soule ME, Estes JA, Miller B, Honnold DL. Strongly interacting species: conservation policy, management, and ethics. Bioscience. 2005;55:168–76.View ArticleGoogle Scholar
  26. Semwal DP, Saradhi PP, Nautiyal BP, Bhatt AB. Current status, distribution and conservation of rare and endangered medicinal plants of Kedarnath Wildlife Sanctuary, Central Himalayas, India. Curr Sci India. 2007;92:1733–8.Google Scholar
  27. Liu C, Yu H, Chen SL. Framework for sustainable use of medicinal plants in China. Zhi Wu Fen Lei Yu Zi Yuan Xue Bao. 2011;33:65–8.Google Scholar
  28. Sheikh K, Ahmad T, Khan MA. Use, exploitation and prospects for conservation: people and plant biodiversity of Naltar Valley, northwestern Karakorums, Pakistan. Biodivers Conserv. 2002;11:715–42.View ArticleGoogle Scholar
  29. Coley PD, Heller MV, Aizprua R, Arauz B, Flores N, Correa M, Gupta M, Solis PN, Ortega-Barría E, Romero LI, Gómez B, Ramos M, Cubilla-Rios L, Capson TL, Kursar TA. Using ecological criteria to design plant collection strategies for drug discovery. Front Ecol Environ. 2003;1:421–8.View ArticleGoogle Scholar
  30. Gepts P. Plant genetic resources conservation and utilization: the accomplishments and future of a societal insurance policy. Crop Sci. 2006;46:2278–92.View ArticleGoogle Scholar
  31. Forest F, Grenyer R, Rouget M, Davies TJ, Cowling RM, Faith DP, Balmford A, Manning JC, Proche S, Bank M, Reeves G, Terry AJ, Savolainen V. Preserving the evolutionary potential of floras in biodiversity hotspots. Nature. 2007;445:757–60.View ArticlePubMedGoogle Scholar
  32. Long CL, Li H, Ouyang ZQ, Yang XY, Li Q, Trangmar B. Strategies for agrobiodiversity conservation and promotion: a case from Yunnan, China. Biodivers Conserv. 2003;12:1145–56.View ArticleGoogle Scholar
  33. Ma J, Rong K, Cheng K. Research and practice on biodiversity in situ conservation in China: progress and prospect. Sheng Wu Duo Yang Xing. 2012;20:551–8.Google Scholar
  34. Volis S, Blecher M. Quasi in situ: a bridge between ex situ and in situ conservation of plants. Biodivers Conserv. 2010;19:2441–54.View ArticleGoogle Scholar
  35. Camm J, Norman S, Polasky S, Solow A. Nature reserve site selection to maximize expected species covered. Oper Res. 2002;50:946–55.View ArticleGoogle Scholar
  36. Rodriguez JP, Brotons L, Bustamante J, Seoane J. The application of predictive modelling of species distribution to biodiversity conservation. Divers Distrib. 2007;13:243–51.View ArticleGoogle Scholar
  37. Chiarucci A, Maccherini S, De Dominicis V. Evaluation and monitoring of the flora in a nature reserve by estimation methods. Biol Conserv. 2001;101:305–14.View ArticleGoogle Scholar
  38. Huang H, Han X, Kang L, Raven P, Jackson PW, Chen Y. Conserving native plants in China. Science. 2002;297:935.View ArticlePubMedGoogle Scholar
  39. Liu J, Linderman M, Ouyang Z, An L, Yang J, Zhang H. Ecological degradation in protected areas: the case of Wolong Nature Reserve for giant pandas. Science. 2001;292:98–101.View ArticlePubMedGoogle Scholar
  40. Kramer AT, Havens K. Plant conservation genetics in a changing world. Trends Plant Sci. 2009;14:599–607.View ArticlePubMedGoogle Scholar
  41. Strandby U, Olsen CS. The importance of understanding trade when designing effective conservation policy: the case of the vulnerable Abies guatemalensis Rehder. Biol Conserv. 2008;141:2959–68.View ArticleGoogle Scholar
  42. Li XW, Chen SL. Conspectus of ecophysiological study on medicinal plant in wild nursery. Zhong Guo Zhong Yao Za Zhi. 2007;32:1388–92.Google Scholar
  43. Havens K, Vitt P, Maunder M, Guerrant EO, Dixon K. Ex situ plant conservation and beyond. Bioscience. 2006;56:525–31.View ArticleGoogle Scholar
  44. Yu H, Xie CX, Song JY, Zhou YQ, Chen SL. TCMGIS-II based prediction of medicinal plant distribution for conservation planning: a case study of Rheum tanguticum. Chin Med. 2010;5:31.View ArticlePubMedPubMed CentralGoogle Scholar
  45. Swarts ND, Dixon KW. Terrestrial orchid conservation in the age of extinction. Ann Bot. 2009;104:543–56.View ArticlePubMedPubMed CentralGoogle Scholar
  46. Pulliam HR. On the relationship between niche and distribution. Ecol Lett. 2000;3:349–61.View ArticleGoogle Scholar
  47. Yuan QJ, Zhang ZY, Hu JA, Guo LP, Shao AJ, Huang LQ. Impacts of recent cultivation on genetic diversity pattern of a medicinal plant, Scutellaria baicalensis (Lamiaceae). BMC Genet. 2010;11:52–9.View ArticleGoogle Scholar
  48. Primack RB, Miller-Rushing AJ. The role of botanical gardens in climate change research. New Phytol. 2009;182:303–13.View ArticlePubMedGoogle Scholar
  49. Maunder M, Higgens S, Culham A. The effectiveness of botanic garden collections in supporting plant conservation: a European case study. Biodivers Conserv. 2001;10:383–401.View ArticleGoogle Scholar
  50. Li DZ, Pritchard HW. The science and economics of ex situ plant conservation. Trends Plant Sci. 2009;14:614–21.View ArticlePubMedGoogle Scholar
  51. Schoen DJ, Brown AHD. The conservation of wild plant species in seed banks. Bioscience. 2001;51:960–6.View ArticleGoogle Scholar
  52. Joshi BC, Joshi RK. The role of medicinal plants in livelihood improvement in Uttarakhand. Int J Herb Med. 2014;1:55–8.Google Scholar
  53. Leung KW, Wong AS. Pharmacology of ginsenosides: a literature review. Chin Med. 2010;5:20.View ArticlePubMedPubMed CentralGoogle Scholar
  54. Raina R, Chand R, Sharma YP. Conservation strategies of some important medicinal plants. Int J Med Aromat Plant. 2011;1:342–7.Google Scholar
  55. Wong KL, Wong RN, Zhang L, Liu WK, Ng TB, Shaw PC, Kwok PCL, Lai YM, Zhang ZJ, Zhang YB, Tong Y, Cheung H, Lu J, Wing SC. Bioactive proteins and peptides isolated from Chinese medicines with pharmaceutical potential. Chin Med. 2014;9:19.View ArticlePubMedPubMed CentralGoogle Scholar
  56. Chan K, Shaw D, Simmonds MS, Leon CJ, Xu Q, Lu A, Sutherland I, Ignatova S, Zhu YP, Verpoorte R, Williamson EM, Duezk P. Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica. J Ethnopharmacol. 2012;140:469–75.View ArticlePubMedGoogle Scholar
  57. Muchugi A, Muluvi GM, Kindt R, Kadu CAC, Simons AJ, Jamnadass RH. Genetic structuring of important medicinal species of genus Warburgia as revealed by AFLP analysis. Tree Genet Genome. 2008;4:787–95.View ArticleGoogle Scholar
  58. Makunga NP, Philander LE, Smith M. Current perspectives on an emerging formal natural products sector in South Africa. J Ethnopharmacol. 2008;119:365–75.View ArticlePubMedGoogle Scholar
  59. Rigby D, Cáceres D. Organic farming and the sustainability of agricultural systems. Agr Syst. 2001;68:21–40.View ArticleGoogle Scholar
  60. Macilwain C. Organic: is it the future of farming? Nature. 2004;428:792–3.View ArticlePubMedGoogle Scholar
  61. Suresh B. Organic farming: status, issues and prospects—a review. Agr Econ Res Rev. 2010;23:343–58.Google Scholar
  62. Baker DD, Chu M, Oza U, Rajgarhia V. The value of natural products to future pharmaceutical discovery. Nat Prod Rep. 2007;24:1225–44.View ArticlePubMedGoogle Scholar
  63. Wang HW, Peng DC, Xie JT. Ginseng leaf-stem: bioactive constituents and pharmacological functions. Chin Med. 2009;4:20.View ArticlePubMedPubMed CentralGoogle Scholar
  64. Rao SR, Ravishankar GA. Plant cell cultures: chemical factories of secondary metabolites. Biotechnol Adv. 2002;20:101–53.View ArticlePubMedGoogle Scholar
  65. Lata H, Chandra S, Khan IA, Elsohly MA. Propagation of Cannabis sativa L using synthetic seed technology. Plant Med. 2008;74:328.View ArticleGoogle Scholar
  66. Zych M, Furmanowa M, Krajewska-Patan A, Lowicka A, Dreger M, Mendlewska S. Micropropagation of Rhodiola kirilowii plants using encapsulated axillary buds and callus. Acta Biol Cracov Bot. 2005;47:83–7.Google Scholar
  67. Schippmann U, Leaman DJ, Cunningham AB. Impact of cultivation and gathering of medicinal plants on biodiversity: global trends and issues. Inter-Department Working Group on biology diversity for food and agriculture. Rome: FAO; 2002.Google Scholar
  68. Teklehaymanot T, Giday M. Ethnobotanical study of medicinal plants used by people in Zegie Peninsula, Northwestern Ethiopia. J Ethnobiol Ethnomed. 2007;3:12–23.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© Chen et al 2016

Advertisement